This page shows the latest commercialisation news and features for those working in and with pharma, biotech and healthcare.
Novartis will have an exclusive licence for further development of the custom ARCUS nuclease, taking charge of all subsequent research, development, manufacturing and commercialisation.
AD). While Almirall holds the licence to develop and commercialise lebrikizumab for the treatment of dermatology indications – including AD – in Europe, Eli Lilly retains the exclusive rights for development and commercialisation
According to the terms of the deal, Shionogi will conduct the clinical trials and subsequent registration and commercialisation of olorofim for IA in Europe and Asia.
partners. Additionally, Horizons will provide intellectual property advice, research commercialisation support and an entrepreneurial programme and £30m of seed funding to help tackle the translational gap.
When the two companies began their research contract in 2016, AbbVie then had the right to acquire a licence for the development and commercialisation of BioArctic's portfolio of alpha-synuclein
spring of 2020 to help us get Moderna ready for commercialisation in record time.
More from news
Approximately 0 fully matching, plus 563 partially matching documents found.
The lines between healthcare, drug discovery, clinical research and commercialisation are blurring, as the patient becomes a key partner and focus.
The life sciences sector needs governments to introduce attractive policies and incentives that will encourage manufacturers to invest in development and commercialisation of biosimilars, to ensure competitive and sustainable supply and
Experts can exist in any part of our industry’s value chain, from discovery to commercialisation and all points in between.
Along with securing investment, they also need to improve the overall implementation of commercialisation.
These partners can help assess the commercial opportunity of external products or portfolios and determine how well they fit with a company’s resources, research focus, and commercialisation strategies.
More from intelligence
Approximately 2 fully matching, plus 134 partially matching documents found.
Stephanie Hill strengthens the commercial team at leading healthcare network. Ashfield, a leader in commercialisation services for the healthcare industry, has appointed Stephanie Hill (pictured above) as its new head of
Dr Germano Ferrari. His most recent role was as a programme manager at the UK’s Cell and Gene Therapy Catapult where he helped develop commercialisation pathways for several pre-clinical
Berman initially joined the biotech back in September last year with the aim to advance the company’s lead candidate IMCgp100 towards commercialisation. ... IMCgp100, towards commercialisation.”.
Her appointment will significantly strengthen Immunocore as we advance our lead candidate, IMCgp100, towards commercialisation, and our growing pipeline of TCR candidates through clinical development.”.
His new role builds on his career history surrounding drug development through to commercialisation in both pharma and biotech industries.
More from appointments
Approximately 0 fully matching, plus 122 partially matching documents found.
Nucleus X Consulting consists of a group of specialist practices, with deep expertise in patient engagement, rare disease, and early-phase medical commercialisation. ... We partner with our clients to drive successful drug commercialisation, leveraging
With accelerated time to commercialisation, early preparation and a tailored launch strategy are essential. ... About Nucleus X Consulting and Nucleus Global. Nucleus X Consulting consists of a group of specialist practices, with deep expertise in
Collaboration. Progress would not be possible without collaboration at all stages in the commercialisation of rare disease drugs, from clinical development to product launch, to those working hard to elevate the ... However, challenges in the
PulmoBioMed is a newly launched Northumbria University spinout, founded by Associate Professor Dr Sterghios Moschos and supported into commercialisation by Chief Executive Officer Dr Pete Hotten, who has over 20 years
a set sequence that risked excluding patient understanding and insight, pre-commercialisation. ... The insight can help build an educational programme that works in part as a pre-commercialisation process.
More from PMHub
Approximately 5 fully matching, plus 40 partially matching documents found.
We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...